Survival Outcome Assessed According to Tumor Burden and Progression Patterns in Patients With Epidermal Growth Factor Receptor Mutant Lung Adenocarcinoma Undergoing Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy
2007 ◽
Vol 26
(6)
◽
pp. 1618-1625
◽
2017 ◽
Vol 51
(4)
◽
pp. 441-443
◽
2012 ◽
Vol 30
(27)
◽
pp. 3330-3336
◽
2021 ◽
Vol 111
(1)
◽
pp. 290-295
2018 ◽
Vol 210
(1)
◽
pp. 43-51
◽
2020 ◽
2014 ◽
Vol 35
(8)
◽
pp. 915